Phenytoin stimulates chondrogenic differentiation in mouse clonal chondrogenic EC cells, ATDC5

Journal of Toxicological Sciences

Volumn 30, Issue 3, 2005, Pages 145-156

  Okada, Akinobu ^a   Shiomi, Teruaki ^a   Aoki, Yoshinobu ^a   Fujiwara, Michio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Antiepileptic drugs; ATDC5; Chondrogenesis; EC cells; Phenytoin

Indexed keywords

AGGRECAN; ALCIAN BLUE; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN TYPE 2; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; PHENOBARBITAL; PHENYTOIN; PROTEIN PATCHED; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VALPROIC ACID;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINE; CHONDROGENESIS; CLONAL VARIATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO CELL; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; ERINACEIDAE; MURINAE;

EID: 24944451116     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.30.145     Document Type: Article

References (42)

1. Akiyama, H., Shigeno, C., Iyama, K., Ito, H., Hiraki, Y., Konishi, J. and Nakamura, T. (1999): Indian hedgehog in the late-phase differentiation in mouse chondrogenic EC cells, ATDC5: Upregulation of type X collagen and osteoprotegerin ligand mRNA. Biochem. Biophys. Res. Commun., 257, 814-820.
2. Akiyama, H., Shukunami, C., Nakamura, T. and Hiraki, Y. (2000): Differential expressions of BMP family genes during chondrogenic differentiation of mouse ATDC5 cells. Cell Struct. Funct., 25, 195-204.
3. Atsumi, T., Miwa, Y., Kimata, K. and Ikawa, Y. (1990): A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev., 30, 109-116.
4. Dansky, L.V. and Finnell, R.H. (1991): Parental epilepsy, anticonvulsant drugs, and reproductive outcome: Epideminologic and experimental findings spanning three decades; 2: human studies. Reprod. Toxicol., 5, 301-335.
5. Enomoto-Iwamoto, M., Nakamura, T., Aikawa, T., Higuchi, Y., Yuasa, T., Yamaguchi, A., Nohno, T., Noji, S., Matsuya, T., Kurisu, K., Koyama, E., Pacifici, M. and Iwamoto, M. (2000): Hedgehog proteins stimulate chondrogenic cell differentiation and cartilage formation. J. Bone Miner. Res., 15, 1659-1668.
6. Finnell, R.H. and Dansky, L.V. (1991): Parental epilepsy, anticonvulsant drugs, and reproductive outcome: Epideminologic and experimental findings spanning three decades; 1: animal studies. Reprod. Toxicol., 5, 281-299.
7. Franklyn, J.A., Davis, J.R., Ramsden, D.B. and Sheppard, M.C. (1985): Phenytoin and thyroid hormone action. J. Endocrinol., 104, 201-204.
8. Goldman, A.S., Sharpior, B.H. and Katsumata, M. (1978): Human foetal palatal corticoid receptors and teratogens for cleft palate. Nature, 272, 464-466.
9. Goldman, A.S. (1984): Biochemical mechanism of glucocorticoid and phenytoin-induced cleft palate. Curr. Top. Dev. Biol., 19, 217-239.
10. Iimura, T., Oida, S., Takeda, K., Maruoka, Y. and Sasaki, S. (1994): Changes in homeobox-containing gene expression during ectopic bone formation induced by bone morphogenetic protein. Biochem. Biophys. Res. Commun., 201, 980-987.
11. Ikedo, D., Ohishi, K., Yamauchi, N., Kataoka, M., Kido, J. and Nagata, T. (1999): Stimulatory effects of phenytoin on osteoblastic differentiation of fetal calvaria cells in culture. Bone, 25, 653-660.
12. Ito, H., Akiyama, H., Shigeno, C. and Nakamura, T. (2000): Parathyroid hormone-related peptide inhibits the expression of bone morphogenetic protein-4 mRNA through a cyclic AMP/protein kinase A pathway in mouse clonal chondrogenic EC cells, ATDC5. Biochim. Biophys. Acta, 1497, 237-243.
13. Johnson, J.P. (1984): Acquired craniofacial features associated with chronic phenytoin therapy. Clin. Pediatr., 23, 671-674.
14. Katsumata, M., Gupta, C., Baker, M.K., Sussdorf, C.E. and Goldman, A.S. (1982): Diphenylhydantoin: An alternative ligand of a glucocorticoid receptor affecting prostaglandin generation in A/J mice. Science, 218, 1313-1315.
15. Katsuyama, M., Gupta, C. and Goldman, A.S. (1985): Glucocorticoid receptor IB: Mediator of anti-inflammatory and teratogenic functions of both glucocorticoids and phenytoin. Arch. Biochem. Biophys., 243, 385-395.
16. Kattan, K.R. (1970): Calvarial thickening after dilantin medication. Am. J. Roentgenol. Radium Ther. Nuclear Med., 110, 102-106.
17. Kawai, J., Akiyama, H., Shigeno, C., Ito, H., Konishi, J. and Nakamura, T. (1999): Effects of transforming growth factor-β signaling on chondrogenesis in mouse chondrogenic EC cells, ATDC5. Eur. J. Cell Biol., 78, 707-714.
18. Kay, E.D., Goldman, A.S. and Daniel, J.C. (1990): Common biochemical pathway of dysmorphogenesis in murine embryos: Use of the glucocorticoid pathway by phenytoin. Teratogenesis Carcinog. Mutagen., 10, 31-39.
19. Kloen, P., Visker, M.H.P.W., Olijve, W., van Zoelen, E.J.J. and Boersma, C.J.C. (1997): Cell-type-specific modulation of hox gene expression by members of the TGF-β superfamily: A comparison between human osteosarcoma and neuroblastoma cell lines. Biochem. Biophys. Res. Commun., 233, 365-369.
20. Kodama, H., Amagai, Y., Sudo, H., Kasai, S. and Yamamoto, S. (1981): Establishment of a clonal osteogenic cell line from newborn mouse calvaria. Jap. J. Oral Biol., 23, 899-901.
21. Lau, K-H.W., Nakade, O., Barr, B., Taylor, A.K., Houchin, K. and Baylink, D.J. (1995): Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo. J. Clin. Endocrinol. Metab., 80, 2347-2353.
22. Lee, K., Lanske, B., Karaplis, A.C., Deeds, J.D., Kohno, H., Nissenson, R.A., Kronenberg, H.M. and Segre, G.V. (1996): Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology, 137, 5109-5118.
23. Lefebvre, E.B., Haining, R.G. and Labbe, R.F. (1972): Coarse facies, calvarial thickening and hyperphosphatasia associated with long-term anticonvulsant therapy. N. Engl. J. Med., 286, 1301-1302.
24. Levy, R.H. (1980): Phenytoin: Biopharmacology. Adv. Neurol., 27, 315-321.
25. Miura, M., Tanaka, K., Komatsu, Y., Suda, M., Yasoda, A., Sakuma, Y., Ozawa, A. and Nakao, K. (2002): Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate. J. Bone Miner. Res., 17, 443-454.
26. Ohta, T., Wergedal, J.E., Gruber, H.E., Baylink, D.J. and Lau, K-H.W. (1995): Low dose phenytoin is an osteogenic agent in the rat. Calsified Tissue Int., 56, 42-48.
27. Okada, A., Ohta, Y., Buchanan, D.L., Sato, T. and Iguchi, T. (2002): Effect of estrogens on ontogenetic expression of progesterone receptor in the fetal female rat reproductive tract. Mol. Cell. Endocrinol., 195, 55-64.
28. Park, C.K., Ishimi, Y., Ohmura, M., Yamaguchi, M. and Ikegami, S. (1997): Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells. J. Nutr. Sci. Vitaminol., 43, 281-296.
29. Ross, S.A., McCaffery, P.J., Drager, U.C. and Luca, L.M. (2000): Retinoids in embryonal development. Physiol. Rev., 80, 1021-1054.
30. Sasaki, H., Ikedo, D., Kataoka, M., Kido, J., Kitamura, S. and Nagata, T. (1999): Pronounced palatal and mandibular tori observed in a patient with chronic phenytoin therapy: A case report. J. Periodontol., 70, 445-448.
31. Schipani, E. and Provot, S. (2003): PTHrP, PTH, and the PTH/PTFrP receptor in endochondral bone development. Birth Defects Res. Part C, 69, 352-362.
32. Shibata, M., Fujino, E., Sato, Y., Numazawa, S., Yoshida, T. and Kuroiwa, Y. (1996): Inhibition of insulin-induced chondrogenic differentiation of embryonic carcinoma cells by a teratogenic compound YM9429. Biochem. Biophys. Res. Commun., 225, 593-599.
33. Shukunami, C., Shigeno, C., Atsumi, T., Ishizeki, K., Suzuki, F. and Hiraki, Y. (1996): Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: Differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell Biol., 133, 457-468.
34. Shukunami, C., Ishizeki, K., Atsumi, T., Ohta, Y., Suzuki, F. and Hiraki, Y. (1997): Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res., 12, 1174-1188.
35. Shukunami, C., Akiyama, H., Nakamura, T. and Hiraki, Y. (2000): Requirement of autocrine signaling by bone morphogenetic protein-4 for chondrogenic differentiation of ATDC5 cells. FEBS Lett., 469, 83-87.
36. Siebler, T., Robson, H., Shalet, S.M. and Wikkiams, G.R. (2002): Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells. Bone, 31, 457-464.
37. Silvestrini, G., Ballanti, P., Patacchioli, F.R., Mocetti, P., Di Grezia, R., Wedard, B.M., Angelucci, L. and Bonucci, E. (2000): Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone, 26, 33-42.
38. Sklans, S., Taylor, R.G. and Shklar, G. (1967): Effect of diphenylhydantoin sodium on healing of experimentally produced fractures in rabbit mandibles. J. Oral Surg., 25, 310-319.
39. Stevens, D.A., Hasserjian, R.P., Robson, H., Siebler, T., Shalet, S.M. and Williams, G.R. (2000): Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J. Bone Miner. Res., 15, 2431-2442.
40. Sudo, H., Kodama, H., Amagai, Y., Yamamoto, S. and Kasai, S. (1983): In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol., 96, 191-198.
41. Vortkamp, A., Lee, K., Lanske, B., Segre, G.V., Kronenberg, H.M. and Tabin, C.J. (1996): Regulation of rate of cartilage differentiation by indian hedgehog and PTH-related protein. Science, 273, 613-622.
42. Waes, J.G.V., Bennett, G.D. and Finnell, R. (1999): Phenytoin-induced alterations in craiofacial gene expression. Teratology, 59, 23-34.